The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer
ByManuel González Barón, MD,Enrique Espinosa, MD,Jaime Feliu, MD,Amalio Ordóñez, MD,Pilar Zamora, MD,Javier De Castro, MD,Carlos García Girón, MD,Pilar García Alfonso, MD,Pilar Garrido, MD,Joaquin Belón, MD,Maria Lomas, MD
Published: | Updated:
Gastric cancer is the most chemosensitive adenocarcinoma among digestive neoplasms. A few years ago, we performed a phase II trial with the FLEP regimen, in which fluorouracil (5-FU) and leucovorin are combined